Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

54.00

+0.50 (0.93%)

as of Jun 5, 2026, 8:00:00 pm Market Open.

1636 watching

Investor Insights

Jun 5, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) is viewed positively by several analysts, who note its solid growth in Asia and the wealth management sector. The company is seen as a stable and reliable option, with a decent dividend yield that appeals to income-focused investors. Analysts acknowledge that while MFC has experienced some recent challenges, especially in its U.S. operations and corrections after strong performances, it maintains a healthy growth outlook. Concerns about the overall market and macroeconomic factors have led to suggestions of caution, but many believe MFC's valuation is still attractive relative to its peers, particularly the banks. In the long term, it remains a compelling investment opportunity with the potential for growth, other factors such as credit risk being minimal.

Consensus

Positive

Valuation

Fair Value

Similar

SLF

BUY

Take profits now? An income stock. Lifecos have done well this year, even though rates are low. MFC reported earnings last week and saw good growth in Asia. Their long-term growth prospects are positive. A long-term hold.

BUY

This would be the best of the life insurers. They have the cheapest valuation, the least leverage and the most opportunity for selling off legacy assets that are holding it back. It is a short term buy.

COMMENT

He used to own Manulife going into the financial crisis and have not looked at it since. It is pale in comparison to Sun Life.

HOLD

Selling insurance plus investments. Core business is doing well. Low interest rates are bad for them, but rates are not going lower. Don't rush out to sell. Good growth in core business. Good valuation. Growth in Asia.

HOLD

He almost picked MFC as a top pick, but it is moving to $25, so he chose another financial. Good earnings growth, mostly Asian. It will benefit from higher interest rates, so low rates prevent it from rising to $30. They will likely raise their dividend, so you can hold this for that dividend.

HOLD

Likes the name. Long-term, overseas operations will benefit the stock price. Insurers are doing better. Up 26% in last 12 months. Nice healthy dividend of 4.1%. (Analysts’ price target is $28.38)

BUY

MFC vs. Arc Arc is riskier while MFC is steadier. MFC is at an excellent price now, close to book value and offers a 12% ROE. Best in this sector with great Asian growth potential. They have a long way to sort out problems with long-term care in the U.S. Arc is good if you want more torque in your portfolio.

COMMENT

$35.19 is his model price, 46% upside. MFC has never gotten any respect, but he watches it. SunLife has better metrics. There's a lot of value in MFC, but financials as a whole are risky now. MFC is stuck in purgatory. Sell if it breaks below $22.60. He owns a little of this. He hasn't made up his mind about MFC.

PAST TOP PICK

(A Top Pick Oct 24/18, Up 22%) There's a lot more gas in the tank. Preferred horse in the life insurance sector. 13% ROE. Trades at 7.5x earnings. Should have a "3" handle on it. Yield is 4.2%.

BUY

Likes the chart and lifecos a lot. There's been a downtrend for 2018 and part of 2019, but we're now in an uptrend, at least rangebound. He expects yields to move higher in the future and that will lift all lifeco stocks. Meanwhile, collect the dividend.

COMMENT

They've diversified out of the interest-rate tail risk by getting more into wealth management. Good. They're growing their India and China presence. But they remain an insurance company, which means they're tied to interest rates. When rates are low, their returns are lower. You can't change a leopard's spots. However, they have raised a lot of capital.

COMMENT

He finds it is a bit of a black box. He finds it hard to understand their business because there are so many moving parts. The banks are more protected from foreign competition or ownership.

HOLD

They raised the dividend late last year and he expects another boost again. They are growing their business in Asia. Margins have been squeezed a bit with lower interest rates, but based on their recent earnings report, they are weathering it well. He thinks there is value up to $28-$30. Yield 4%

HOLD

The stock is cheap and he holds it in the portfolio. Trades at a low price to book value. Yield 4.5%

COMMENT

This and SLF have been diversifying. MFC is pushing their wealth management business and increasingly from the Asian market. He's gun-shy on MFC. He used to own it.

Showing 346 to 360 of 2,279 entries

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Most Recent Experts

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Joe Terranova

Virtus Investment Partners

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)